In the article by Kallio et al., 1 the authors compared the results of free flap transfer with or without revascularisation. The authors report positive results in the group without necessary revascularization of the ulcer region and acceptable results in the other two groups. 1 The study provides a large single centre series about this topic, and the authors are to be congratulated for their efforts in the surgery, treatment, and follow up of these patients, most of whom would have experienced major limb amputation sooner or later.
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The data are presented clearly and give hope that this may be an additional method for limb salvage in diabetic patients with non-healing wounds or ulcers.
Nevertheless, there are some points that should be discussed and mentioned before recommending such an extensive therapy given the time and costs.
As can be seen in this study, the authors have done about five free flap transfers per year for diabetic foot lesions. Thus, it should be clear that this procedure is a rare and selected one for these patients, and that the indications for this therapeutic modality are negatively selected and failures of previous therapies.
In many cases, the described modality seems to be the last attempt before major amputation. Hence we can only analyse/collect data retrospectively and with changing methodologies over this long time period. These limitations restrict what data can be obtained, but the collection of prospective data or randomisation is not ethically feasible and thus the presented study is the best possible for longterm follow up.
Another issue is the selection of the free flap for transfer. The authors have chosen latissimus dorsi (38), rectus abdominis (11), fascio-cutaneus forearm (8), serratus muscle (2), gracilis (1), adductor (1), vastus lateralis (1), and parascapularis (1) flaps in this study design. While there are surely many arguments for the choice of these flaps, a recommendation for the best free flap seems weakened by the wide variety used. It is difficult to say with certainty which flap is the most promising in which position in the leg.
Looking at the patient characteristics, it must be stated that the selected patients are younger and affected by fewer comorbidities than the usual diabetic patients in a vascular surgeon's everyday practice. A 90 year old patient with disabilities and significant comorbidities would definitely not be the right patient for this approach, and the use of the method needs to be carefully considered for each patient.
Despite these critical comments, it is important to realise that all of the patients treated in this study have had a history of various therapeutic approaches and were designated for major amputation. With this in mind, 61% limb salvage in the long term is a good result that should be available for all patients who may profit from this procedure. To identify these patients is the most challenging aspect of it, because only with good results do the complexity and efforts of this treatment seem justified.
Again, the authors are to be congratulated for their work and the presentation of the approach in this well written paper.
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